Oral Pyronaridine Tetraphosphate Reduces Tissue Presence of Parasites in a Mouse Model of Chagas Disease
Jair Lage Siqueira-Neto,
Thomas R. Lane,
Jean A. Bernatchez,
Claudia Magalhaes Calvet Alvarez,
Elany Barbosa da Silva,
Miriam A. Giardini,
Sean Ekins
Affiliations
Jair Lage Siqueira-Neto
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States
Thomas R. Lane
Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States
Jean A. Bernatchez
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States
Claudia Magalhaes Calvet Alvarez
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States
Elany Barbosa da Silva
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States
Miriam A. Giardini
Center for Discovery and Innovation in Parasitic Diseases, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, United States
Sean Ekins
Collaborations Pharmaceuticals, Inc., Raleigh, North Carolina, United States
